EUVIMEDEUVIMED entdecken
Crossref

Twenty‐year outcome of prevalence, incidence, mortality and survival rate in patients with malignant bone tumors

Yao Xu, Fanqi Shi, Yanting Zhang, Mengfan Yin, Xiuxin Han, Jinyan Feng, Guowen Wang iD

International Journal of Cancer · 15.01.2024 · 154 (2) · 226-240

DOI: 10.1002/ijc.34694 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 19.08.2023. Verfasst von Yao Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Ti…. Hauptthemen laut MEDLINE: Sarcoma, Ewing, Chordoma, Bone Neoplasms, Osteosarcoma. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Tianjin Key Medical Discipline (Specialty) Construction Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malignant bone tumors are a group of rare malignant tumors and our study aimed to update the recent epidemiologic estimates based on the Surveillance, Epidemiology and End Results database. Patients diagnosed with malignant bone tumors from 2000 to 2019 were included and their characteristics were retrospectively described. The limited‐duration prevalence, annual age‐adjusted incidence and mortality were calculated, and the annual percentage changes were analyzed to quantify the rate change. Finally, observed survival and relative survival rate were illustrated. Subgroup analysis across tumor type, age, gender, tumor Grade, primary tumor site and stage was also performed. As for results, a total of 11 655 eligible patients with malignant bone tumor were selected. Osteosarcoma was the most common tumor type, followed by chondrosarcoma, Ewing sarcoma and chordoma. The estimated limited‐duration prevalence of malignant bone tumors increased from 2000 (0.00069%) to 2018 (0.00749%). Steady age‐adjusted incidence was observed in all patients during the study period while the highest rate occurred in osteosarcoma. Mortality rates differed in subgroups while elder patients (older than 64 years) presented the highest mortality rate compared to other age groups. In all bone tumors, the 10‐year observed survival and relative survival rates were 58.0% and 61.9%, respectively. Chondrosarcoma patients had the best survival outcome, followed by osteosarcoma, Ewing sarcoma, chordoma and other bone tumors. In conclusion, different epidemiologic performance in incidence and mortality was observed across tumor type as well as other demographic and clinicopathological variables, which provide potential suggestion for further adjustment of medical resource.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sarcoma, EwingChordomaBone NeoplasmsOsteosarcomaChondrosarcomaHumansAgedSurvival RateIncidencePrevalenceRetrospective Studies

Stichwörter der Autor:innen

SEER programbone neoplasmsincidencemortalityprevalencesurvival rate

Autor:innen und Institutionen

  • Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
  • Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
  • Department of Spinal Surgery, The Affiliated Hospital of Chengde Medical University, Chengde, Hebei, China.
  • Department of Orthopedics, The Fifth Central Hospital of Tianjin, Tianjin, China.

ORCID-Profile: Guowen Wang

Förderung

  • National Natural Science Foundation of China
  • Tianjin Key Medical Discipline (Specialty) Construction Project

Zitieren

APA

Xu, Y., Shi, F., Zhang, Y., Yin, M., Han, X., Feng, J., & Wang, G. (2024). Twenty‐year outcome of prevalence, incidence, mortality and survival rate in patients with malignant bone tumors. International Journal of Cancer, 154(2), 226-240. https://doi.org/10.1002/ijc.34694

Vancouver

Xu Y, Shi F, Zhang Y, Yin M, Han X, Feng J, et al. Twenty‐year outcome of prevalence, incidence, mortality and survival rate in patients with malignant bone tumors. International Journal of Cancer. 2024;154(2):226-240. doi:10.1002/ijc.34694

BibTeX
@article{Xu2024,
  author = {Xu, Yao and Shi, Fanqi and Zhang, Yanting and Yin, Mengfan and Han, Xiuxin and Feng, Jinyan and Wang, Guowen},
  title = {Twenty‐year outcome of prevalence, incidence, mortality and survival rate in patients with malignant bone tumors},
  journal = {International Journal of Cancer},
  year = {2024},
  volume = {154},
  number = {2},
  pages = {226--240},
  doi = {10.1002/ijc.34694}
}
Kostenlos starten →